毒理学药物筛选市场－全球产业规模、份额、趋势、机会和预测，按检测类型、产品、应用、地区和竞争格局划分，2020-2030年预测

全球毒理学药物筛选市场规模将从2024年的121.6亿美元成长到2030年的198.4亿美元，复合年增长率（CAGR）为8.50%。毒理学药物筛选是指在药物发现和开发的初期阶段，系统性地评估新型药物化合物对生物系统的潜在不良反应。该市场的成长主要得益于全球药物研发投入的不断攀升，而这要求在进入临床试验之前进行严格的安全性评估。

主要市场驱动因素

全球毒理学药物筛选市场的扩张受到製药研发投入不断增长的显着影响。随着製药公司投入大量资金用于新药的发现和开发，全面、早期毒性评估的重要性也日益凸显。

主要市场挑战

影响全球毒理学药物筛选市场的关键挑战因素在于，开发和验证能够准确预测体内人体毒性的体外模型极为复杂且成本高昂。这直接阻碍了市场扩张，为先进筛选技术的广泛应用设置了重大障碍。

主要市场趋势

全球毒理学药物筛选市场受到复杂体外模型（例如晶片器官和3D细胞培养技术）进步的显着影响。与传统的2D细胞培养相比，这些模型具有更高的生理相关性，能够更精确地模拟人体生物学和药物反应。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球毒理学药物筛选市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依测试类型（体外、体内、电脑模拟）
  • 依产品分类（仪器、试剂及耗材、动物模型、软体、其他产品）
  • 依应用（免疫毒性、全身毒性、发育和生殖毒性 (DART)、内分泌干扰、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美毒理学药物筛选市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲毒理学药物筛选市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区毒理学药物筛选市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲毒理学药物筛选市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲毒理学药物筛选市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球毒理学药物筛选市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Merck KGaA
• Charles River Laboratories International, Inc.
• Enzo Life Sciences Inc.
• Eurofins Scientific SE
• Danaher Corporation
• Laboratory Corporation of America Holdings
• Promega Corporation
• The Jackson Laboratory

第十六章：策略建议

第17章调查会社について・免责事项

The Global Toxicology Drug Screening Market will grow from USD 12.16 Billion in 2024 to USD 19.84 Billion by 2030 at a 8.50% CAGR. Toxicology drug screening involves the systematic evaluation of potential adverse effects of novel pharmaceutical compounds on biological systems during the initial stages of drug discovery and development. This market's expansion is fundamentally propelled by escalating global pharmaceutical research and development expenditures, which necessitate rigorous safety assessments before advancing to clinical trials.

Key Market Drivers

The expansion of the global toxicology drug screening market is significantly influenced by increasing pharmaceutical research and development investments. As pharmaceutical companies commit substantial capital to the discovery and development of novel drug candidates, the imperative for comprehensive and early-stage toxicity assessment grows. This commitment is exemplified by major industry players.

Key Market Challenges

A key challenging factor impacting the global toxicology drug screening market is the considerable complexity and inherent costs associated with developing and validating *in vitro* models that accurately forecast *in vivo* human toxicity. This directly hampers market expansion by creating significant barriers to the widespread adoption of advanced screening technologies. Pharmaceutical companies face substantial financial outlays in both the initial development and the subsequent rigorous validation required to ensure these *in vitro* models reliably predict human physiological responses.

Key Market Trends

The global toxicology drug screening market is significantly shaped by advancements in complex in vitro models, such as organ-on-a-chip and 3D cell culture technologies. These models offer enhanced physiological relevance compared to traditional 2D cell cultures, providing a more accurate representation of human biology and drug responses. Their adoption helps to reduce reliance on animal testing and can improve the predictive accuracy of preclinical toxicity assessments.

Key Market Players

• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Merck KGaA
• Charles River Laboratories International, Inc.
• Enzo Life Sciences Inc.
• Eurofins Scientific SE
• Danaher Corporation
• Laboratory Corporation of America Holdings
• Promega Corporation
• The Jackson Laboratory

Report Scope:

In this report, the Global Toxicology Drug Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Toxicology Drug Screening Market, By Testing Type:

• In Vitro
• In Vivo
• In Silico

Toxicology Drug Screening Market, By Product:

• Instruments
• Reagents and Consumables
• Animal Models
• Software
• Other Products

Toxicology Drug Screening Market, By Application:

• Immunotoxicity
• Systemic toxicity
• Developmental and Reproductive Toxicity (DART)
• Endocrine Disruption
• Other

Toxicology Drug Screening Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Toxicology Drug Screening Market.

Available Customizations:

Global Toxicology Drug Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Toxicology Drug Screening Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Testing Type (In Vitro, In Vivo, In Silico)
  • 5.2.2. By Product (Instruments, Reagents and Consumables, Animal Models, Software, Other Products)
  • 5.2.3. By Application (Immunotoxicity, Systemic toxicity, Developmental and Reproductive Toxicity (DART), Endocrine Disruption, Other)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Toxicology Drug Screening Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Testing Type
  • 6.2.2. By Product
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Toxicology Drug Screening Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Testing Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Toxicology Drug Screening Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Testing Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Toxicology Drug Screening Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Testing Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Application

7. Europe Toxicology Drug Screening Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Testing Type
  • 7.2.2. By Product
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Toxicology Drug Screening Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Testing Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Application
  • 7.3.2. France Toxicology Drug Screening Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Testing Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Toxicology Drug Screening Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Testing Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Toxicology Drug Screening Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Testing Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Toxicology Drug Screening Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Testing Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Application

8. Asia Pacific Toxicology Drug Screening Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Testing Type
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Toxicology Drug Screening Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Testing Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Application
  • 8.3.2. India Toxicology Drug Screening Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Testing Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Toxicology Drug Screening Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Testing Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Toxicology Drug Screening Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Testing Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Toxicology Drug Screening Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Testing Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Application

9. Middle East & Africa Toxicology Drug Screening Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Testing Type
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Toxicology Drug Screening Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Testing Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Toxicology Drug Screening Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Testing Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Toxicology Drug Screening Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Testing Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Application

10. South America Toxicology Drug Screening Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Testing Type
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Toxicology Drug Screening Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Testing Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Toxicology Drug Screening Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Testing Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Toxicology Drug Screening Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Testing Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Toxicology Drug Screening Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bio-Rad Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Agilent Technologies, Inc.
• 15.3. Merck KGaA
• 15.4. Charles River Laboratories International, Inc.
• 15.5. Enzo Life Sciences Inc.
• 15.6. Eurofins Scientific SE
• 15.7. Danaher Corporation
• 15.8. Laboratory Corporation of America Holdings
• 15.9. Promega Corporation
• 15.10. The Jackson Laboratory

16. Strategic Recommendations

17. About Us & Disclaimer